Antiretroviral therapy in HIV-infected adolescents: clinical and pharmacologic challenges

References

• Steinberg L. Cognitive and affective development in adolescence. Trends Cogn Sci. 2005; 9(2): 69–74.
   PubMed Web of Science ®Google Scholar
• Mitchell KJ, Ybarra ML, Korchmaros JD, et al. Accessing sexual health information online: use, motivations and consequences for youth with different sexual orientations. Health Educ Res. 2014; 29(1):147–157.
   PubMed Web of Science ®Google Scholar
• Hornberger LL. Adolescent psychosocial growth and development. J Pediatr Adolesc Gynecol. 2006; 19(3):243–246.
   PubMedGoogle Scholar
• Steinberg L, Mounts NS, Lamborn SD, et al. Authoritative parenting and adolescent adjustment across varied ecological niches. Adolescents and Their Families: Structure, Function, and Parent–Youth Relations. 2013; 2(1):129.
   Google Scholar
• Steinberg L. Risk taking in adolescence new perspectives from brain and behavioral science. Curr Dir Psychol Sci. 2007; 16(2):55–59.
   Web of Science ®Google Scholar
• Adams PE, Martinez ME, Vickerie JL, et al. Summary health statistics for the US population: National Health Interview Survey, 2010. Vital and health statistics. Series 10. Data from the National Health Survey. Hyattsville, MD: U.S. Department of Health and Human Services. 2011; 251:1–117.
   Google Scholar
• Jones PB. Adult mental health disorders and their age at onset. Br J Psychiatry. 2013; 54 (Suppl):s5–s10.
   Google Scholar
• Neinstein LS, Irwin CE Jr. Young adults remain worse off than adolescents. J Adolesc Health. 2013; 53(5):559–561.
   PubMed Web of Science ®Google Scholar
• Wood SM, Shah SS, Steenhoff AP, et al. The impact of AIDS diagnoses on long-term neurocognitive and psychiatric outcomes of surviving adolescents with perinatally acquired HIV. Aids, 2009;23(14):1859–1865.
   PubMed Web of Science ®Google Scholar
• Mellins CA, Malee KM. Understanding the mental health of youth living with perinatal HIV infection: lessons learned and current challenges. J Int AIDS Soc. 2013; 16:18593
   PubMed Web of Science ®Google Scholar
• Sweeney SM, Vanable PA. The association of HIV-related stigma to HIV medication adherence: A systematic review and synthesis of the literature. AIDS Behav. 2016; 20:29–50.
   PubMed Web of Science ®Google Scholar
• Adejumo OA, Malee KM, Ryscavage P, et al. Contemporary issues on the epidemiology and antiretroviral adherence of HIV-infected adolescents in sub-Saharan Africa: a narrative review. J Int AIDS Soc. 2015; 18:20049.
   PubMed Web of Science ®Google Scholar
• Malow RM, Kershaw T, Sipsma H, et al. HIV preventive interventions for adolescents: A look back and ahead. Curr HIV/AIDS Rep. 2007; 4:173–180
   PubMedGoogle Scholar
• 2012 New York City Child Fatality Report. http://www.nyc.gov/html/doh/downloads/pdf/ip/ip-nyc-inj-child-fatality-report12.pdf
   Google Scholar
• New York State Community Action Association(NYSCAA) . New York State Poverty Report. March 2013.http://ams.nyscommunityaction.org/Resources/Documents/News/NYSCAAs2013Poverty_Report.pdf
   Google Scholar
• National Poverty Center. The University of Michigan Gerald R. Ford School of Public Policy. Poverty in the United States. http://www.npc.umich.edu/poverty/
   Google Scholar
• Foster C, Fidler S. Optimizing antiretroviral therapy in adolescents with perinatally acquired HIV-1 infection. Expert Rev Anti Infect Ther. 2010; 8(12):1403–1416 .
   PubMed Web of Science ®Google Scholar
• Rosenberg MG, Abadi J, Dobroszycki J, et al. Progress and challenges in antiretroviral therapy for HIV-infected children. Curr Infect Dis Rep. 2006; 8:324–331
   Google Scholar
• Dobroszycki J, Abadi J, Wiznia AA, et al. Profile of darunavir in the treatment of HIV-infected pediatric and adolescent patients. Adolesc Health Med Ther. 2011; 2:85–93.
   PubMedGoogle Scholar
• Mofenson LM, Cotton MF. The challenges of success: adolescents with perinatal HIV infection. J Int AIDS Soc. 2013, 16:18650
   PubMed Web of Science ®Google Scholar
• Sohn AH, Hazra R. The changing epidemiology of the global paediatric HIV epidemic: keeping track of perinatally HIV-infected adolescents. J Int AIDS Soc. 2013, 16:18555
   PubMed Web of Science ®Google Scholar
• Hazra R, Siberry GK, Mofenson LM. Growing up with HIV: children, adolescents, and young adults with perinatally acquired HIV infection. Annu Rev Med 2010; 61:169–185.
   PubMed Web of Science ®Google Scholar
• Smith R, Chernoff M, Williams PL, et al. Impact of HIV severity on cognitive and adaptive functioning during childhood and adolescence. Pediatr Infect Dis J. 2012; 31(6):592–598.
   PubMed Web of Science ®Google Scholar
• Farmer C, Yehia BR, Fleischman JA, et al. Factors associated with retention among non–perinatally HIV-infected youth in the HIV research network. J Pediatric Infect Dis Soc. 2016; 5 (1):39–46.
   PubMed Web of Science ®Google Scholar
• Hudelson C, Cluver L. Factors associated with adherence to antiretroviral therapy among adolescents living with HIV/AIDS in low and middle-income countries: a systematic review. 2015. ADIS Care; 27:805–816
   PubMed Web of Science ®Google Scholar
• Agwu AL, Lee L, Fleishman JA, et al. Aging and loss to follow-up among youth living with human immunodeficiency virus in the HIV research network. J Adolesc Health. 2015; 56(3): 345–351
   PubMed Web of Science ®Google Scholar
• Agwu AL, Siberry GK, Ellen J, et al. Predictors of HAART utilization for behaviorally HIV-1 infected youth: impact of adult vs. pediatric clinical care site. J Adolesc Health 2012; 50(5): 471–477.
   PubMed Web of Science ®Google Scholar
• Munjal I, Dobroszycki J, Fakioglu E, et al. Impact of HIV-1 infection and pregnancy on maternal health: comparison between perinatally and behaviorally infected young women. Adolesc Health Med Ther. 2013; 4:51–58.
   PubMedGoogle Scholar
• Wilkins ML, Dallas RH, Porter JS, et al. Characterizing body image in youth with HIV. AIDS Behav. 2015 Dec 31. [ Epub ahead of print]
   Web of Science ®Google Scholar
• Ybarra ML, Bull SS. Current trends in internet and cell-phone-based HIV prevention and intervention programs. Curr HIV/AIDS Rep. 2007; 4:201–207
   PubMedGoogle Scholar
• Rana Y, Haberer J, Huang H, et al. Short Message Service (SMS)-based intervention to improve treatment adherence among HIV-positive youth in Uganda: focus group findings. Plos ONE. 2015; 10(4): e0125187.
   Web of Science ®Google Scholar
• Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department Health Hum Serv [Accessed 26 April 2016].
   Google Scholar
• Hein K. Developmental pharmacology in adolescence. The inauguration of a new field. J Adolesc Health Care 1987; 8 (1):1–4.
   PubMedGoogle Scholar
• Hein K. Introduction to the special issue on pharmacokinetics and pharmacodynamics in adolescents. J Adolesc Health. 1994; 15 (8): 609–611.
   PubMed Web of Science ®Google Scholar
• Rakhmanina NY, Capparelli EV, Anker JN. Personalized therapeutics: HIV treatment in adolescents. Clin Pharmacol Ther. 2008; 84: 734–740 .
   PubMed Web of Science ®Google Scholar
• Department of Health and Human Services. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents: what’s new in the guidelines. 2016 [Accessed 26 April 2016]. https://aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-treatment-guidelines/0
   Google Scholar
• Antiretroviral Therapy for HIV Infection in Infants and Children: Towards Universal Access: Recommendations for a Public Health Approach: 2010 Revision. Geneva: World Health Organization; 2010. Annex H, Sexual Maturity Rating (Tanner Staging) in Adolescents. [cited 2016 May 24]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK138588/.
   Google Scholar
• Stang J, Story M. Chapter 1: adolescent growth and development. Stang J, Story M (eds) Guidelines for Adolescent Nutrition Services. 2005; http://www.epi.umn.edu/let/pubs/adol_book.shtm
   Google Scholar
• Chavers BM, Rheault MN, Foley RN. Kidney function reference values in US adolescents: national health and nutrition examination survey 1999–2008. Clin J Am Soc Nephrol. 2011; 6 (8): 1956–1962.
   PubMed Web of Science ®Google Scholar
• Hoste L, Dubourg L, Selistre L, et al. A new equation to estimate the glomerular filtration rate in children, adolescents and young adults. Nephrol Dial Transplant. 2014; 29(5):1082–1091.
   PubMed Web of Science ®Google Scholar
• Rathbun RC, Liedtke MD. Antiretroviral drug interactions: overview of interactions involving new and investigational agents and the role of therapeutic drug monitoring for management. Pharmaceutics. 2011; 3(4): 745–781.
   PubMedGoogle Scholar
• Kearns GL, Abdel-Rahman SM, Alander SW, et al. Developmental pharmacology–drug disposition, action, and therapy in infants and children. N Engl J Med. 2003.18; 349(12):1157–1167.
   PubMed Web of Science ®Google Scholar
• Blanco JG, Harrison PL, Evans WE, et al. Human cytochrome P450 maximal activities in pediatric versus adult liver. Drug Metab Dispos. 2000; 28(4):379–382.
   PubMed Web of Science ®Google Scholar
• Saag M, Balu R, Phillips E, et al. High sensitivity of human leucocyte antigen-B57*01 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients. Clin Inf Dis. 2008; 46:1111–1118
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. HIV Surveillance Report, 2014; vol. 26.http://www.cdc.gov/hiv/library/reports/surveillance/. Published November 2015.
   Google Scholar
• Drugs that Fight HIV-1. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. [cited 2016 May 9]. Available from: https://aidsinfo.nih.gov/contentfiles/hiv_pill_brochure.pdf
   Google Scholar
• Lexicomp Online®, Pediatric & Neonatal Lexi-Drugs®, Hudson, Ohio: Lexi-Comp, Inc.; 2016; March 24 2016.
   Google Scholar
• Strom CM, Goos D, Crossley B, et al. Testing for variants in CYP2C19: population frequencies and testing experience in a clinical laboratory. Genet Med. 2012; 14(1):95–100.
   PubMed Web of Science ®Google Scholar
• Antoniou T, Tseng A. Interactions between recreational drugs and antiretroviral agents. Ann Pharmacother. 2002; 36:1598–1613.
   PubMed Web of Science ®Google Scholar
• McDowell JA, Chittick GE, Stevens CP, et al. Pharmacokinetic interaction of abacavir (1592U89) and ethanol in human immunodeficiency virus-infected adults. Antimicrob Agents Chemother. 2000; 44(6):1686–1690.
   PubMed Web of Science ®Google Scholar
• Toronto General Hospital. Immunodeficiency Clinic. Drug Interaction Tables. Accessed at: http://hivclinic.ca/main/drugs_interact_files/Oral%20Contraceptive-int.pdf
   Google Scholar
• Kredo T, Van Der Walt JS, Siegfried N, et al. Therapeutic drug monitoring of antiretrovirals for people with HIV. Cochrane Database Syst Rev. 2009; 3:CD007268.
   Google Scholar
• Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents: Management of the Treatment-Experienced Patient Exposure-Response Relationship and Therapeutic Drug Monitoring (TDM) for Antiretroviral Agents. 2016. [cited 2016 May 5]. Available from: https://aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-arv-guidelines/17/exposure-responserelationship-and-therapeutic-drug-monitoring–tdm–for-antiretroviral-agents
   Google Scholar
• Dehority W, Abadi J, Wiznia A, et al. Use of integrase inhibitors in HIV-infected children and adolescents. Drugs. 2015; 75(13):1483–1497.
   PubMed Web of Science ®Google Scholar
• Nachman S, Zheng N, Acosta EP, et al. Pharmacokinetics, safety, and 48-week efficacy of oral raltegravir in HIV-1-infected children aged 2 through 18 years. Clin Infect Dis. 2014; 58(3):413–422.
   PubMed Web of Science ®Google Scholar
• Lindeman TA, Duggan JM, Sahloff EG. Evaluation of serum creatinine changes with integrase inhibitor use in human immunodeficiency virus-1 infected adults. Open Forum Infect Dis. 2016, 3(2):ofw053
   PubMed Web of Science ®Google Scholar
• Messiaen P, Wensing AM, Fun A, et al. Clinical use of HIV integrase inhibitors: a systematic review and meta-analysis. Plos One. 2013 Jan 9;8(1):e52562
   PubMed Web of Science ®Google Scholar
• Tudor-Williams G, Cahn P, Chokephaibulkit K, et al. Etravirine in treatment-experienced, HIV-1-infected children and adolescents: 48-week safety, efficacy and resistance analysis of the phase II PIANO study. HIV Med. 2014; 15(9):513–524.
   PubMed Web of Science ®Google Scholar
• Lombaard J, Bunupuradah T, Flynn P, et al. Week 48 safety and efficacy of a rilpivirine (TMC278)-based regimen in HIV-infected treatment-naïve adolescents: PAINT phase II trial. Oral Presented at the 8th IAS Conference on HIV Pathogenesis, Treatment and Prevention. Vancouver July 19-22, 2015
   Google Scholar
• De Clerq E. Tenofovir alafenamide (TAF) as the successor of tenofovir disoproxil fumarate (TDF). Biochem Pharmacol. 2016; April 29. [ Epub ahead of print]
   Web of Science ®Google Scholar